Chinese Regulatory Probe Confirmed as Cause of OPay's Aborted $304 Million NYSE IPO
A 2023 Chinese regulation requiring state approval for overseas listings of companies holding significant data has been identified as the specific rule that forced OPay to abort its $304 million NYSE IPO. OPay has stated the postponement will not affect its operations, while analysts continue to frame the episode as a landmark reset moment for African fintech public market ambitions.
OPay IPO: the founder's passport killed the listing
OPay built its entire legal argument on one claim: Beijing has no jurisdiction here, because every dollar earned, every asset held, every office opened is outside mainland China.
That argument was airtight on paper. Then China's 2023 overseas listing rules — which let regulators pierce offshore structures and examine who is ultimately in charge — did exactly that. Zhou Yahui is Chinese. That was enough to open an inquiry.
The uncomfortable truth for every African fintech backed by non-African capital: the company's legal home, revenue geography, and operational footprint may not be what a foreign regulator sees. They see the founder.
2 sources
- Chinese regulatory inquiry forced OPay to halt $300 million US IPO · innovation-village.com · T2
- The 2023 Chinese rule that may have stalled OPay’s US listing · techcabal.com · T1